Mcclellan William D. Jr. - Net Worth and Insider Trading
Mcclellan William D. Jr. Net Worth
The estimated net worth of Mcclellan William D. Jr. is at least $1 Million dollars as of 2024-05-26. Mcclellan William D. Jr. is the Director of Reata Pharmaceuticals Inc and owns about 6,017 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $1 Million. Mcclellan William D. Jr. is also the Director of Apollo Endosurgery Inc and owns about 2,000 shares of Apollo Endosurgery Inc (APEN) stock worth over $20,000. Details can be seen in Mcclellan William D. Jr.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mcclellan William D. Jr. has not made any transactions after 2023-07-28 and currently still holds the listed stock(s).
Transaction Summary of Mcclellan William D. Jr.
Mcclellan William D. Jr. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mcclellan William D. Jr. owns 2 companies in total, including Reata Pharmaceuticals Inc (RETA) , and Apollo Endosurgery Inc (APEN) .
Click here to see the complete history of Mcclellan William D. Jr.’s form 4 insider trades.
Insider Ownership Summary of Mcclellan William D. Jr.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RETA | Reata Pharmaceuticals Inc | 2023-09-26 | director |
| APEN | Apollo Endosurgery Inc | 2017-05-17 | director |
Mcclellan William D. Jr. Latest Holdings Summary
Mcclellan William D. Jr. currently owns a total of 2 stocks. Among these stocks, Mcclellan William D. Jr. owns 6,017 shares of Reata Pharmaceuticals Inc (RETA) as of July 28, 2023, with a value of $1 Million and a weighting of 98.11%. Mcclellan William D. Jr. also owns 2,000 shares of Apollo Endosurgery Inc (APEN) as of May 17, 2017, with a value of $20,000 and a weighting of 1.89%.
Latest Holdings of Mcclellan William D. Jr.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RETA | Reata Pharmaceuticals Inc | 2023-07-28 | 6,017 | 172.36 | 1,037,090 |
| APEN | Apollo Endosurgery Inc | 2017-05-17 | 2,000 | 10.00 | 20,000 |
Holding Weightings of Mcclellan William D. Jr.
Mcclellan William D. Jr. Form 4 Trading Tracker
According to the SEC Form 4 filings, Mcclellan William D. Jr. has made a total of 3 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Reata Pharmaceuticals Inc is the sale of 5,000 shares on July 28, 2023, which brought Mcclellan William D. Jr. around $822,450.
According to the SEC Form 4 filings, Mcclellan William D. Jr. has made a total of 0 transactions in Apollo Endosurgery Inc (APEN) over the past 5 years. The most-recent trade in Apollo Endosurgery Inc is the acquisition of 2,000 shares on May 17, 2017, which cost Mcclellan William D. Jr. around $12,660.
Insider Trading History of Mcclellan William D. Jr.
- 1
Mcclellan William D. Jr. Trading Performance
GuruFocus tracks the stock performance after each of Mcclellan William D. Jr.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mcclellan William D. Jr. is -32.61%. GuruFocus also compares Mcclellan William D. Jr.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Mcclellan William D. Jr. within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mcclellan William D. Jr.'s insider trading performs compared to the benchmark.
Performance of Mcclellan William D. Jr.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.97 | | | | | |
| Relative Return to S&P 500(%) | 1.74 | | | | | |
Mcclellan William D. Jr. Ownership Network
Mcclellan William D. Jr. Owned Company Details
What does Reata Pharmaceuticals Inc do?
Who are the key executives at Reata Pharmaceuticals Inc?
Mcclellan William D. Jr. is the director of Reata Pharmaceuticals Inc. Other key executives at Reata Pharmaceuticals Inc include director & 10 percent owner Antal Rohit Desai , SVP & Chief Accounting Officer Bhaskar Anand , and EVP & Chief R&D Officer Rajiv Patni .
Reata Pharmaceuticals Inc (RETA) Insider Trades Summary
Over the past 18 months, Mcclellan William D. Jr. made 1 insider transaction in Reata Pharmaceuticals Inc (RETA) with a net sale of 5,000. Other recent insider transactions involving Reata Pharmaceuticals Inc (RETA) include a net sale of 185,892 shares made by Manmeet Singh Soni , a net sale of 150,995 shares made by Dawn Carter Bir , and a net sale of 2,880 shares made by Bhaskar Anand .
In summary, during the past 3 months, insiders sold 0 shares of Reata Pharmaceuticals Inc (RETA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 530,967 shares of Reata Pharmaceuticals Inc (RETA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 530,967 shares.
Reata Pharmaceuticals Inc (RETA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reata Pharmaceuticals Inc Insider Transactions
Mcclellan William D. Jr. Mailing Address
Above is the net worth, insider trading, and ownership report for Mcclellan William D. Jr.. You might contact Mcclellan William D. Jr. via mailing address: C/o Apollo Endosurgery, Inc., 1120 S., Capital Of Texas Hwy, Bldg. 1, Suite 300, Austin Tx 78746.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
